Showing results (2441-2450 of 3,896) with videos related to
Sort By:
Pageof 390
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2003
Amygdala volumetry in "imaging-negative" temporal lobe epilepsyS P C Bower, S J Vogrin, K Morris, et al.Journal of Chemical Ecology|December 20, 2003
Responses of the aphids Phorodon humuli and Rhopalosiphum padi to sex pheromone stereochemistry in the fieldColin A M Campbell, Fraser J Cook, John A Pickett, et al.Neurology|March 13, 2002
Clinical, EEG, and quantitative MRI differences in pediatric frontal and temporal lobe epilepsyJ A Lawson, M J Cook, S Vogrin, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2019
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatmentKaren D Bosch, Sugama Chicklore, Gary J Cook, et al.The Journal of Cell Biology|September 28, 2005
Lithium induces autophagy by inhibiting inositol monophosphataseSovan Sarkar, R Andres Floto, Zdenek Berger, et al.European Archives of Psychiatry and Clinical Neuroscience|June 27, 2024
Effects of cognitive behavioural therapy and exposure-response prevention on brain activation in obsessive-compulsive disorder patients: systematic review and meta-analysisCallum Stephenson, Aaron Philipp-Muller, Elnaz Moghimi, et al.Brain Research. Brain Research Protocols|May 10, 2005
A brightness-area-product-based protocol for the quantitative assessment of antigen abundance in fluorescent immunohistochemistryPaul D Smith, Karen J McLean, Michael A Murphy, et al.Journal of General Internal Medicine|May 17, 2022
The 3 Wishes Program Improves Families' Experience of Emotional and Spiritual Support at the End of LifeThanh H Neville, Zachary Taich, Anne M Walling, et al.Epilepsy & Behavior : E&B|February 12, 2020
Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsyJohanna Sofia Moraes, Graham Hepworth, Sophia Ignatiadis, et al.The Biochemical Journal|April 5, 2023
ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1Kathryn Balmanno, Andrew M Kidger, Dominic P Byrne, et al.Pageof 390